Bionomics Limited (NASDAQ:BNOX – Get Free Report) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 120,400 shares, a growth of 12.4% from the August 31st total of 107,100 shares. Based on an average trading volume of 901,000 shares, the short-interest ratio is presently 0.1 days.
Bionomics Stock Performance
Shares of NASDAQ:BNOX traded up $0.01 during trading on Friday, reaching $0.64. The stock had a trading volume of 119,341 shares, compared to its average volume of 447,413. The business’s 50-day moving average price is $0.64 and its 200 day moving average price is $0.81. Bionomics has a 52 week low of $0.50 and a 52 week high of $6.41.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reiterated a “buy” rating and issued a $8.00 target price on shares of Bionomics in a research note on Thursday, August 1st.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Bionomics stock. Armistice Capital LLC acquired a new position in Bionomics Limited (NASDAQ:BNOX – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 1,226,759 shares of the company’s stock, valued at approximately $941,000. Armistice Capital LLC owned about 15.03% of Bionomics at the end of the most recent reporting period. Hedge funds and other institutional investors own 15.90% of the company’s stock.
About Bionomics
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder.
Featured Articles
- Five stocks we like better than Bionomics
- How to Choose Top Rated Stocks
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- How to Effectively Use the MarketBeat Ratings Screener
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to Use the MarketBeat Excel Dividend Calculator
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for Bionomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionomics and related companies with MarketBeat.com's FREE daily email newsletter.